Infertility Hall A
Friday, November 21, 2014 08:30-10:30
Hot topics: what is the answer?
Debate: The need for LH effects in antagonist protocols Yes: Dominique de Ziegler, France; No: Roy Homburg, Israel Endometriosis, COS response and ART outcome: Chii-Ruey Tzeng, Taiwan The thin endometrium: pathophysiology and treatment options: David Barad, USA
10:30-11:00
Coffee Break
11:00-12:45
Leaders’ Views on the Future: keynote lectures
Opening remarks: Nguyen Viet Tien, Vietnam, Honorary President, Vice Ministry of Health, Chairman of the Vietnam Association of Gynecology, Obstetrics & Family Planning Zeev Shoham, Israel, Congress Co-Chairperson Artificial ovary: Why and how? Marie Madeleine Dolmans, Belgium Artificial gametes: Gerald Schatten, USA The evolving technology of ultrasound in medicine: Israel Shapiro, Israel Producing offspring from artificial gametes: Katsuhiko Hayashi, Japan
12:45-13:30 Lunch 13:30-15:30
Fertility preservation of oocytes and ovarian tissue: an open discussion about the procedures
New aspects in basic research of female fertility preservation: TBA Ovarian freezing and transplantation to preserve fertility in cancer patients provide fertility solutions and raise a lot of controversial issues in addition: Claus Yding Andersen, Denmark Ovarian tissue freezing and grafting: From cancer to benign diseases to social reasons: Jacques Donnez, Belgium Oocyte verification is the best method for fertility preservation: Masashigi Kuwayama, Japan
15:30-16:00
Coffee Break
16:00-18:00 PCOS Debate: With the use of the GnRH agonist trigger (in an antagonist protocol) there is no role for IVM in for the prevention of OHSS For the motion: Seang Lin Tan, Canada; Against the motion: Ho Manh Tuong, Vietnam Individual COS- What is it? Can we apply it? What are the benefits for your practice? Colin M Howles, Switzerland Treatment strategies for the infertile PCO patient: Shahar Kol, Israel
SATURday, November 22, 2014 08:30-10:30 Preimplantation genetic diagnosis & screening – What is it all about?
State of the art of PGD and PGS: Andreas Schmutzler, Germany Does PGS improve IVF outcomes in older women? Simon Fishel, UK Time-lapse imaging: is this the future? Milton Leong, Hong Kong Oocyte- and patient-specific factors influencing embryo morphokinetics and implantation: Simon Fishel, UK
10:30-11:00
Coffee Break
11:00-13:00 Preparing ovaries for IVF in women with low functional ovarian reserve
Improving the prognosis for poor responder patients Molecular changes in ovarian follicles with advancing female age: David Barad, USA Adjusting ovarian stimulation to patient age Is it worthwhile treating women above age 40? Norbert Gleicher, USA Luteal-phase ovarian stimulation in IVF: the present and the future: Yanping Kuang, China IVF outcome in extremely poor prognosis patients: Ariel Weissman, Israel
13:00-14:00 Lunch 14:00-16:00 Unexplained infertility: a challenging condition Debate: Unexplained infertility is caused by early ovarian ageing Pro: Frank Broekmans, The Netherlands; Con: Salim Daya, Canada Debate: COH vs. minimal stimulation: safe stimulation Moderator: John Yovich, Australia Minimal stimulation completely removes the risk of OHSS and has other advantages: Daniel Bodri, Japan Smart COH can avoid OHSS: Frank Broekmans, The Netherlands
16:00-16:30
Coffee Break
16:30-18:30
Adjuvants for poor-prognosis patients
Debate: The re-growth of growth hormones in fertility treatment For: John Yovich, Australia; Against: Roy Homburg, Israel Debate: Does dehydroepiandrosterone (DHEA) supplementation really affect IVF-ICSI outcome in women with poor ovarian reserve? For: Norbert Gleicher, USA; Against: Salim Daya, Canada